The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2019

Filed:

Feb. 23, 2016
Applicant:

Biomadison, Inc., Del Mar, CA (US);

Inventors:

Timothy M. Piazza, McFarland, WI (US);

Ward C. Tucker, Monona, WI (US);

Assignee:

BIOMADISON, INC., Del Mar, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/37 (2006.01); G01N 33/50 (2006.01); G01N 33/58 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5014 (2013.01); C12Q 1/37 (2013.01); G01N 33/56911 (2013.01); G01N 33/582 (2013.01); G01N 2333/33 (2013.01); G01N 2333/952 (2013.01);
Abstract

Apparatus, systems and methods can provide improved detection of botulinum neurotoxins. In one aspect an isoquinolynyl compound can be used to enhance the sensitivity of both Förster resonance energy transfer (FRET) and non-FRET cell-based assays. In another aspect, non-FRET assays and constructs utilize a reporter that is not coupled with the second fluorophore in a manner that produces significant FRET. In that subject matter an environment cell can include an enzyme that facilitates degradation of the reporter significantly faster after the cleavage than before the cleavage, and presence of the Botulinum toxin correlates with reduction of the signal from a baseline signal. Where the environment is a cell, the cell can advantageously express both the construct that includes the reporter, and an enzyme that facilitates the degradation.


Find Patent Forward Citations

Loading…